×

Archive The Faber Report

  Friday, 12 Dec 2014 | 9:42 AM ET

Low oil hits high-yield bonds

Posted ByDavid Faber
CNBC's David Faber reports on violent movements in some bond funds as concerns surface about possible high-yield contagion. »Read more
  Thursday, 11 Dec 2014 | 9:38 AM ET

Credit market concerns surface

Posted ByDavid Faber
CNBC's David Faber discusses the tumultuous high-yield market and the larger issue of the lack of leveraged buyouts. »Read more
  Wednesday, 10 Dec 2014 | 9:38 AM ET

Faber Report: Content is king

Posted ByDavid Faber
CNBC's David Faber speaks to big media CEOs about the need for quality content and if demand will drive up price. »Read more
  Monday, 8 Dec 2014 | 9:38 AM ET

Supreme Court rejects BP's Gulf challenge

Posted ByDavid Faber
CNBC's David Faber and Jim Cramer discuss the Supreme Court's decision to reject BP's Gulf settlement challenge. »Read more
  Friday, 5 Dec 2014 | 9:48 AM ET

Duel for Family Dollar: Faber

Posted ByDavid Faber
CNBC's David Faber reports the update on Dollar Tree's deal to merge with Family Dollar. »Read more
  Thursday, 4 Dec 2014 | 9:41 AM ET

CBS blackout deadline nears

Posted ByDavid Faber
CNBC's David Faber reports on the standoff between CBS and the DISH Network to reach an agreement. »Read more
  Tuesday, 25 Nov 2014 | 9:37 AM ET

Harbinger's Falcone resigns

Posted ByDavid Faber
CNBC's David Faber reports on the resignation of Phil Falcone as chief executive at Harbinger Capital Partners. »Read more
  Thursday, 20 Nov 2014 | 9:42 AM ET

Faber Report: Dish soars amid spectrum auction

Posted ByDavid Faber
CNBC's David Faber reports the government auction of wireless spectrum is boosting the value of Dish Networks. »Read more
  Friday, 7 Nov 2014 | 9:44 AM ET

Faber Report: Ackman's letter to Allergan

Posted ByDavid Faber
CNBC's David Faber reports on the letter Bill Ackman wrote to Allergan, regarding Actavis' interest in the company. »Read more
  Thursday, 6 Nov 2014 | 10:25 AM ET

Allergan-Actavis discussions continue

Posted ByDavid Faber
CNBC's David Faber reports on a new disclosure from Allergan regarding talks with Actavis. »Read more